Prostate Conference Takes Up Question Of Which Genes To Test And How To Counsel Patients At Risk Of Inherited Disease

OncLive (11/18, Narozniak) reports “the key messages that emerged from the 2019 Philadelphia Prostate Cancer Consensus Conference” were that although there have been “many advancements in understanding the role of germline mutations in prostate cancer, a...